コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erequisite to become a long-lived protective memory T cell.
2 eatures of central memory and stem cell-like memory T cells.
3 ion of pathogen-specific CD8 tissue-resident memory T cells.
4 y CD4(+) T cells but enhanced that of CD8(+) memory T cells.
5 by increased levels of TCF7(+) naive and/or memory T cells.
6 hanced and accelerated development of CD8(+) memory T cells.
7 ctivation after they return to quiescence as memory T cells.
8 okine release that resembled those of normal memory T cells.
9 ced phenotype of central memory and effector memory T cells.
10 y with CD8(+)CD103(+)CD69(+) tissue-resident memory T cells.
11 in-domain containing-3 (Tim-3) expression on memory T cells.
12 ed by a site-specific recruitment process of memory T cells.
13 T, an inhibitory molecule on CD8(+) effector memory T cells.
14 o elevated pretransplant frequencies of CD28 memory T cells.
15 d their differentiation into tissue-resident memory T cells.
16 e T cells, and generation and maintenance of memory T cells.
17 p that is otherwise required by conventional memory T cells.
18 companied by increased frequency of effector memory T cells.
19 to generate memory precursors and long-lived memory T cells.
20 states and a novel subset of tissue-resident memory T cells.
21 inst future immune challenges is mediated by memory T cells.
22 tome toward a profile of more differentiated memory T cells.
23 cell subsets, that is, naive, effector, and memory T cells.
24 oxic features that is distinct from effector memory T cells.
25 tribute to the maintenance of viral-specific memory T cells.
26 is a marker for long-lived antigen-specific memory T cells.
27 and minimized CD4(+)CD103(+) tissue-resident memory T cells.
28 nctional CD44(high)CD62L(high)CD8(+) central memory T cells.
29 transcriptionally distinct stem-like CD8(+) memory T cells.
30 haracteristics compared to naive and central memory T cells.
31 creased Bhlhe40(+) Th1-like cells and CD8(+) memory T cells.
32 n and induces a population of stem cell-like memory T cells.
33 l of WNT transcription factor TCF7-dependent memory T cells.
34 r immunity, including CD8(+) tissue-resident memory T cells.
35 not in naive ferrets, suggests induction of memory T-cells.
36 infiltration of antitumor CD8+ effector and memory T-cells.
37 companied by increased frequency of effector memory T-cells.
38 r cytokines supported the finding that CCR9+ memory T cells acquire a more inflammatory profile in SP
40 he establishment of circulating and resident memory T cells after foodborne Listeria monocytogenes in
41 diated B cell depletion on CD4(+) and CD8(+) memory T cell alloresponses after skin transplantation i
42 , and IL-12, successfully stimulates central memory T cells and achieves long-term survival in an agg
43 ion-protective human lymphoid tissue central memory T cells and autoimmune-protective human blood reg
45 ction of CD44(high)CD62L(low)CD8(+) effector memory T cells and CD103(high)CD8(+) tissue-resident T c
47 ckade (ICB) increases the number of effector memory T cells and completely eradicates 4T1 tumors in m
48 g reduced CD4(+) central memory and effector memory T cells and diminished systemic interferon-gamma
49 rized by expansion of IL17A+ CD161+ effector memory T cells and IL17A+ T-regulatory cells; expansion
50 ling and differentiation, expanding effector-memory T cells and inducing robust viral reactivation in
51 igher IFN-gamma production in peripheral CD4 memory T cells and lymph node-derived follicular helper
52 adaptive memory cells, including follicular memory T cells and memory B cells (B(mems)), that are ei
56 reported that AQP4 is expressed by naive and memory T cells and that AQP4 blockade with a small molec
57 rotection by generating central and effector memory T cells and the most recently described tissue re
58 w discusses recent updates on the biology of memory T cells and their relevance to the field of trans
59 stem T cell, central memory T cell, effector memory T cell, and terminally differentiated effector T
61 ized by a metabolism typical of quiescent or memory T cells, and did not participate in inflammatory
62 significantly enhanced local control, CD8(+) memory T cells, and induced preferential T-cell homing v
65 (2019) show that virus-unspecific bystander memory T cells are highly affected during chronic viral
66 latory elements of the cytokine genes in the memory T cells are marked by activating histone modifica
67 we show that protein vaccine-elicited CD4(+) memory T cells are recalled and boosted after infection
71 ment is accompanied by increased circulating memory T cells, as well as fewer effectors, suggesting a
72 causal variants, implicating CD4 + effector memory T cells, as well as monocytes, B cells and stroma
76 IFN-gamma and granzyme-B secreting effector memory T cells but remain as long-lived and hyperprolife
77 required for residence of epidermal-resident memory T cells, but whether skin-derived signals also af
80 Previous work has shown that tissue-resident memory T cells can be established by "pulling" virus-spe
83 in the proportion of CCR9+ cells among CD4+ memory T cells (%CCR9) in SPMS did not correlate with ag
88 splayed decreased numbers of tissue-resident memory T cells compared with H1N1-infected mice; however
92 doptive transfer studies indicate that these memory T cells develop in a cell-intrinsic manner follow
93 conceptual advances in our understanding of memory T cell development that incorporate data describi
94 affinity independently contribute to CD8(+) memory T cell development, which is modulated by inflamm
95 IK is an important regulator of effector and memory T cell differentiation and induces a population o
97 as in turn significantly associated with CD8 memory T-cell differentiation (effector memory, naive, a
99 1 persists as an integrated genome in CD4(+) memory T cells during effective therapy, and cessation o
101 of naive T cell, memory stem T cell, central memory T cell, effector memory T cell, and terminally di
102 LA-DQ8 transgenic (model 2), and the gliadin memory T-cell enteropathy (model 3) models of celiac dis
103 lluminate how targeting pathways that induce memory T cell exhaustion can promote allograft tolerance
104 n as antigen-presenting cells for intragraft memory T cell expansion but not to alloantibody producti
105 road changes in adaptive immunity, including memory T-cell expansion, and rising prevalence of diabet
109 fferentially affected effector T cell versus memory T cell fates, respectively, highlighting their di
111 ompetitive disadvantage resulting in reduced memory T cell formation and maintenance and reduced resp
112 rogresses from naive to central and effector memory T cells, forming an effectorness gradient accompa
114 uantified as a reduction in splenic effector memory T cell frequencies and splenic T helper 17 cells
115 d CD4(+) naive and increased CD4(+) effector memory T cell frequencies were associated with improved
117 timulation and cell enrichment of peripheral memory T cells from six metastatic cancer patients, we i
118 ures to analysis of islet Ag-reactive CD4(+) memory T cells from the blood of T1D and HC individuals
119 cy-reversing agents (LRAs) in ex vivo CD4(+) memory T cells from virally suppressed HIV-infected indi
120 secondary infection with influenza PR8, and memory T-cell function and T-cell metabolism were measur
121 pite the decreased number of tissue-resident memory T cells, H5N1 (2:6) was protected against a heter
123 s the expression of CD103 on tissue-resident memory T cells, has been implicated in HIV latency.
126 or the detection of rare neoantigen-specific memory T cells in cancer patients for studying cellular
128 ata demonstrate the accumulation of effector memory T cells in obese SAT and an association between s
129 chanics, and effector responses between CD8+ memory T cells in peripheral vs. lymphoid organs, reveal
130 as associated with the emergence of effector memory T cells in responding patients, while nonresponde
131 with proinflammatory and activated effector memory T cells in the blood, evidence of treatment effic
132 infections generate antigen-specific CD8(+) memory T cells in the brain that adopt a unique T(RM) si
133 einfection, a sizeable fraction of secondary memory T cells in the circulation developed downstream o
134 upport the accumulation of HCV-specific CD8+ memory T cells in the infected liver, and emphasize the
135 view, we will discuss how influenza-specific memory T cells in the lung are established and maintaine
136 CCR9 and found a reduced frequency of CCR9+ memory T cells in the peripheral blood of patients with
142 r, our data provide characterization of skin memory T cells in vitiligo, demonstrate that Trm and Tcm
145 rthermore, lymphatic exudate was enriched in memory T cells, including tumor-reactive CD137(+) and st
146 sociated lncRNA abrogates IFNG expression by memory T cells, indicating these lncRNAs have biologic f
147 d provides new insights into the location of memory T cells infected with HIV-1 DNA, which is capable
149 ating 3 gene (LAG3) was detected among CCR9+ memory T cells isolated from the CSF, similar to that ob
150 onment impacts the phenotype and function of memory T cells, it is crucial to study these cells withi
151 Finally, supernatants from IL-1beta-treated memory T cells killed Escherichia coli in an IL-26-depen
153 of memory T cells and screening of naive and memory T cell libraries, combined with T cell cloning an
154 n entering the ES T cells assumed a resident memory T cell-like phenotype in the absence of infection
156 ence and characterization of tissue resident memory T cells, manipulation of T cell metabolic pathway
157 aintenance of CD4(+)CD103(+) tissue-resident memory T cells, needed to replenish the vasculitic infil
159 , we postulate that the alterations in CCR9+ memory T cells observed, caused by either the gut microb
162 rios for the impact of cross-reactive CD4(+) memory T cells on COVID-19 severity and viral transmissi
164 s that VZV-specific PCs and VZV-specific CD4 memory T cells persist up to 20 years after vaccination.
165 ntified an EOMES(+)CD69(+)CD45RO(+) effector memory T cell phenotype that was significantly more abun
166 xpand memory T cell pool exhibiting effector memory T cell phenotype, therefore offering great potent
168 xpand memory T-cell pool exhibiting effector memory T-cell phenotype, therefore offering great potent
171 ver, which when lost resulted in a decreased memory T cell pool and thus a reduced secondary response
172 demonstrating its strong capacity to expand memory T cell pool exhibiting effector memory T cell phe
173 Multiple HCMV-directed specificities in the memory T cell pool of single individuals indicate that p
175 differentiation programs in the human CD8(+) memory T cell pool, with potentially broad implications
176 memory cells and rejoin the tissue-resident memory T-cell pool after cessation of IL-10 production.
177 demonstrating its strong capacity to expand memory T-cell pool exhibiting effector memory T-cell phe
180 ared phenotypic properties with the effector memory T cell population but were transcriptionally and
182 y and in the development of the effector and memory T cell populations that mediate long-term resista
183 T(RM) cells align closely with conventional memory T cell populations, bearing little resemblance to
184 me to have stem cell-like properties akin to memory T cell populations, but the developmental relatio
185 ls was required for the optimal formation of memory T cell populations, in particular TRM cell popula
191 agocytic capacity, enhanced ability to drive memory T cell proliferation in coculture, and skewed CD4
192 Chronic antigen stimulation drives CD8+ memory T cell proliferation while also inducing genome-w
193 with potent effector function but maintained memory T cell qualities and conferred robust protection
196 s technique to take full advantage of CD4(+) memory T-cell repertoires when designing immunotherapeut
197 ggest that white adipose tissue represents a memory T cell reservoir that provides potent and rapid e
199 on and results in a CXCR5+ CCR7+ Tfh/central memory T cell response that persists well after parasite
200 response against the antigen, higher central memory T cell response, and lower regulatory T cell resp
201 ental steps are involved to elicit extensive memory T cell response: stimulation of naive T cells wit
204 expression of MHC-II and CD86, and induced a memory T-cell response, attenuating tumor onset and grow
205 za mortality and is associated with impaired memory T-cell response, resulting in increased risk of i
206 B cell depletion also impaired allospecific memory T cell responses and thereby enhanced donor hemat
209 RSV M-null infection generated serum Ab and memory T cell responses that were similar to those induc
211 ts broadly directed and functionally replete memory T cell responses, suggesting that natural exposur
212 that exogenous IL-33 boosts vaccine-induced memory T cell responses, which protect against subsequen
215 nsion culture assay was also used to analyze memory T cell responses.RESULTSWe found responses to the
216 moted long-lasting, antigen-specific central memory T cell responses; and acted as a self-propelled v
218 eased rates of hospitalization and decreased memory T-cell responses to tetanus vaccine were associat
223 s associated with potent antiviral function: memory T cells secreted cytokines and expanded upon anti
224 -4 coinhibitory signals to control naive and memory T cells, selective antagonists of CD28-CD80/86 in
229 changes in human CD4(+) and CD8(+) naive and memory T cell subsets at greater resolution using polych
231 easingly clear that the terms used to define memory T cell subsets no longer accurately reflect our u
234 emia is associated with specific clusters of memory T-cell subsets and lower frequencies of HCMV-spec
235 ory cytokines and the relative proportion of memory T-cell subsets depending on Mtb infection status.
236 Following secondary influenza infection, memory T-cell subsets in the lungs of obese mice were de
238 ute effector T cell (T(AEFF)) to an effector memory T cell (T(EM)) phenotype with progressive enrichm
240 the frequency of circulating CD4(+) central memory T cells (T(CM)) (CD45RO(+)CD62L(+)) in new-onset
241 beit transient, depletion of CD8(+) effector memory T cells (T(EM)) (but not the naive and central me
242 ain high frequencies of circulating effector memory T cells (T(EM)) providing continuous, life-long a
244 surface markers characteristic of naive-like memory T cells (T(NLM)), which were induced in both huma
249 t of memory T cells known as CD8(+) resident memory T cells (T(RM)) are long-lived, nonmigratory memo
250 NKT cells (iNKT) and CD8(+) tissue-resident memory T cells (T(RM)) express high levels of the extrac
256 lation of unconventional CD44+CD122+ virtual memory T cells (T(VM)) has been described that possesses
257 e identified and isolated CD4(+), and CD8(+) memory T cells targeting the mutated KRAS(G12D) and KRAS
260 her pre-treatment frequency of CD4 + central memory T cells (TCM) in patients who were subsequently A
261 we observed increased numbers of BAL central memory T-cells (Tcm), evidence of Type I polarization, a
262 unofluorescence to characterize CD8 effector memory T cell (TEM) populations in the periphery and gra
263 from classically described cytotoxic CD4(+) memory T cells that accumulate during other persistent v
264 resulting in the generation of effector and memory T cells that are then critical for immune clearan
266 e been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated an
267 aptive immunity, differentiating into CD8(+) memory T cells that form the basis of protective cellula
268 odies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months.
270 stinguish CD8-MP cells from bona fide CD8(+) memory T cells, the developmental origins and antigen sp
272 on depletion of circulating and perivascular memory T cells, this brain signature was enriched and th
273 8 T cell response and reduces the ability of memory T cells to be recruited to the site of infection
276 n of airway T(RM) cells and splenic effector-memory T cells transferred into the airways indicated th
280 dence emphasizes the role of tissue-resident memory T cells (TRM) in the defense against recurring pa
281 tant in the establishment of tissue-resident memory T cells (Trm) in the lung tissue following influe
282 Numerous observations indicate that resident memory T cells (TRM) undergo unusually rapid attrition w
284 adult mice, lung-localized, tissue-resident memory T cells (TRMs) mediate optimal protection to resp
285 of human resting naive, central and effector memory T cells using ChIP-Seq and found that unlike the
286 notypes of peanut-activated, CD154(+) CD4(+) memory T cells using fluorescence-activated cell sorting
288 The tolerant state of the Helios-deficient memory T cells was not cell-intrinsic but was due to a s
290 of both effector memory T cells and central memory T cells were reduced, whereas naive T cells incre
291 ened activation of SMX-NO-specific naive and memory T cells, whereas blockade of TIM-3 produced no ef
292 onment and similarities with tissue-resident memory T cells, which are more radio-resistant than circ
294 tients had higher percentages of CD4 and CD8 memory T cells with a concomitant decrease in frequency
295 responding donors have A68/NP(145)(+)CD8(+) memory T cells with clonally expanded TCRalphabetas, whi
296 6dimCD57+NKG2C+ NK cells are similar to CD8+ memory T cells with rapid and robust effector function u
298 pression of IFNG and IFNG-AS1 was evident in memory T cells, with high expression of this long non-co
299 ndent myeloma control, most efficiently from memory T cells within myeloma-experienced grafts, but al
300 sses many, though not all, features of "true memory" T cells, without the requirement of first encoun